marginally significantP = 0.07
3d ) in the validation cohort and was marginally significant ( r = − 0.48, P = 0.07) in one of the two discovery cohorts where total symptom scores were available (Additional file 1 : Figure S1).
3d ) in the validation cohort and was marginally significant ( r = − 0.48, P = 0.07) in one of the two discovery cohorts where total symptom scores were available (Additional file 1 : Figure S1).
We identified a nonsignificant trend of reduced proportions of HSPCs in asymptomatic nonshedders prior to influenza exposure.